Lipella Pharmaceuticals Enters Material Definitive Agreement
Ticker: LIPO · Form: 8-K · Filed: Apr 7, 2025 · CIK: 1347242
| Field | Detail |
|---|---|
| Company | Lipella Pharmaceuticals Inc. (LIPO) |
| Form Type | 8-K |
| Filed Date | Apr 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing-update
TL;DR
Lipella Pharma signed a big deal on 4/4, filing shows. Details to come.
AI Summary
Lipella Pharmaceuticals Inc. announced on April 7, 2025, that it entered into a material definitive agreement on April 4, 2025. The filing also includes financial statements and exhibits related to this agreement. The company is incorporated in Delaware and its principal executive office is located in Pittsburgh, PA.
Why It Matters
This filing indicates a significant new contract or partnership for Lipella Pharmaceuticals, which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Entering into a material definitive agreement is a significant event, but the lack of specific details about the agreement in this initial filing introduces uncertainty.
Key Players & Entities
- Lipella Pharmaceuticals Inc. (company) — Registrant
- April 7, 2025 (date) — Date of Report
- April 4, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Pittsburgh, PA (location) — Principal executive office
FAQ
What is the nature of the material definitive agreement entered into by Lipella Pharmaceuticals?
The filing states that Lipella Pharmaceuticals Inc. entered into a material definitive agreement on April 4, 2025, but does not provide specific details about the agreement's terms or counterparty.
When was the material definitive agreement entered into?
The material definitive agreement was entered into on April 4, 2025.
What is the filing date for this 8-K report?
This 8-K report was filed on April 7, 2025.
Where is Lipella Pharmaceuticals Inc. headquartered?
Lipella Pharmaceuticals Inc.'s principal executive office is located at 7800 Susquehanna St., Suite 505, Pittsburgh, PA 15208.
What is the state of incorporation for Lipella Pharmaceuticals Inc.?
Lipella Pharmaceuticals Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 7, 2025 regarding LIPELLA PHARMACEUTICALS INC. (LIPO).